Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 31, 2001

View Archived Issues

Scotia Moves Into Administration Following Rejection Of Foscan

Mouse Embryo Development Hinges On Sperm Entry Point

ExonHit Sets Up Shop In U.S., Expands Into Heart Diseases

Eurogene Acquires Quattrogene, Phase II Product In Stock Deal

UK Approves Human Embryo Cloning; Ethics Debate Coming

French Researchers Show Value Of Stem Cells In Hair Follicles

New UK BIA Chairman Pushes Industry To Go On Offensive

Draft Report Sparks Debate Among European Ministers

German Government Commits DM1.5B To Biotech Research

Other News To Note

IDgene Raises $7.6M Privately For Genetic Variability Program

PPL Gets £42M Commitment For AAT Manufacturing Facility

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....